MID-CONTINENT UNIVERSITY

Drug & Alcohol Education and Testing Program for Student-Athletes

• To protect the health, safety and welfare of the student-athlete;
• To address, identify and treat student-athletes' problems and concerns surrounding drug use, alcohol consumption and their abuses;
• To inform and educate the student-athlete, and others associated with athletic teams about drugs and alcohol, and the effects of their use/abuse;
• To protect the institution's integrity; and
• To seek to maintain "fair play" in intercollegiate athletics by MCU athletes.

1. When a prospective student-athlete is awarded an athletic grant-in-aid, a copy of the student-athlete's handbook will be given to them. The MCU Drug and Alcohol Education and Testing Program will be included in the handbook. Prior to signing any potential grant-in-aid, the prospective student-athlete will acknowledge receipt and understanding of the Program and will voluntarily consent to participate in the program (if the prospective student-athlete is under eighteen (18) years of age at the time of signing, the parent or guardian will also acknowledge the receipt, understanding and consent for the prospective student-athlete to participate in the program).
2. A presentation will be made to each athletic team in order to outline and review MCU's Drug and Alcohol Education and Testing Program, its purposes, implementation and sanctions.  A copy of the program will be given to the student-athletes at their team orientation meeting. They will be asked, yearly, to sign a form acknowledging receipt and understanding of the program and providing voluntary consent to participate in the program (if the student-athlete is under eighteen (18) years of age at the time of signing, the parent or guardian will be faxed a copy of the program and will acknowledge by return fax the receipt, understanding and consent for the student-athlete to participate in the program).
3. Any student-athlete who does not wish to sign the Consent Form may choose not to do so and will forego participation in intercollegiate athletics.  Student-athletes are free to refuse to consent to drug testing under this Program. However, student-athletes who decline participation in the program, which is designed to protect the health and welfare of the student-athlete, will not be permitted to participate in intercollegiate athletics for MCU and may result in loss of financial aid.
4. A student-athlete who fails to submit to drug testing as provided in this program, after initially consenting to such testing, shall be considered to have made a decision not to participate in the program and will be immediately eliminated from all athletic activity, and may result in loss of financial aid.

• To educate, inform and teach those associated with intercollegiate athletics how to recognize the warning signs and side effects of specific drugs.
• To educate the student-athlete and other appropriate personnel about the associated problems of drug and alcohol abuse and how such use may adversely affect the student-athlete and his/her team and teammates.
• To encourage discussion about the use of drugs and consumption of alcohol.
• Outline rehabilitation and treatment programs as well as referral centers.

1. Each team and coaching staff will meet annually and at such other times as deemed necessary by the Drug and Alcohol Education and Testing Committee, for educational sessions which will focus on, but not be limited to, information regarding the dangers of using performance-enhancing substances, illegal substances and alcohol.
2. Attendance of the student-athlete at scheduled educational sessions is mandatory. Absence will be permitted only with the approval of the Director of Athletics. All absences will result in the student-athlete being required to attend a make-up session.
3. Athletic trainers, student-athletic trainers, team physicians and other responsible personnel should participate in these educational sessions. All coaches are expected to attend a drug education training session each year.
4. Appropriate athletics department personnel will be expected to attend MCU & NAIA drug and alcohol education seminars, national clinics and seminars, and to participate in departmental drug education training sessions in order to be informed of current information.

1. The purpose of the counseling component is to provide assistance, direction, and resources for student-athletes who need additional support as a result of positive tests, physician referral, or self-addressed needs. This component seeks to provide appropriate follow-up and rehabilitation of student-athletes testing positive while addressing their psychological, social and medical well being.
2. Counseling will be provided by trained specialists identified by the MCU Director of Intercollegiate Athletics. Referrals will originate with the Team Physician, or other designee, who shall be involved in developing an appropriate treatment plan. Counseling will be confidential.

1. General Provisions:
   1. The testing program will consist of two types of testing:
      1. Random drug testing for "performance enhancing" drugs (as listed in Appendix A), "street drugs" (as listed in Appendix B) and alcohol.
      2. Reasonable suspicion drug testing for "performance enhancing" drugs (as listed in Appendix A), "street drugs" (as listed in Appendix B) and alcohol.
   2. The protocol for specimen collection, chain of custody and the University's responses to positive tests shall be followed for random as well as reasonable suspicion drug testing.
   3. Independent of the provisions in subsection E, and as is the practice with all medical concerns, the team physician may prohibit athletic competition and/or participation by any student-athlete for such time as deemed medically necessary. Restrictions should be sufficient to ensure that the student-athlete's condition no longer presents a health danger to himself/herself or his/her teammates.
   4. Records of test results will be handled in accordance with strict standards of confidentiality, being maintained by the Director of the Professional Athletic Training Program, and released only under the circumstances allowed by the provisions of this Program or as otherwise required by law.
2. Random Drug Testing
   1. As part of the student-athlete's annual pre-season medical screening, an initial urine specimen may be collected from each participant.  Although the testing selection process may be random, a computerized system or similar mechanism (which will be documented) may be used, to ensure that all athletes are equally eligible for testing.  For those sports in which a given substance is more likely to be abused, a participating student-athlete will be more likely to be tested.
   2. A student-athlete who has been selected for testing, prior to giving a urine sample, may "self-identify" that they have a drug-related problem and will test positive. By self-identifying the student-athlete will be granted a one time in their athletic career "one time exemption". At this time the student-athlete will be tested and only the Director of Intercollegiate Athletics, the team physician and intervention counselor will be notified of this positive test result. As long as the student-athlete continues with the required treatment and/or counseling program no further sanctions will be imposed upon the student-athlete. Failure to continue with the Program will initiate further notifications and sanctions from the Department of Intercollegiate Athletics as outlined in subsection E as defined for the student-athlete who did not "self-identify". Student-athletes, at anytime, who realize that they have drug related problems are encouraged to seek assistance by contacting the Director of Intercollegiate Athletics and "self-identifying". Testing and treatment will be initiated. If this is their first positive the "one time exemption" will be granted. If this is their second or third positive they may also initiate the Appeals process (Appeals subsection F), and their "self-identifying" will be taken into consideration.
   3. Once notified, the Director of Intercollegiate Athletics and the Team Physician will notify the student-athlete of a positive result. The Director of Intercollegiate Athletics and/or the Team Physician will also notify the Head Coach, Intervention Counselor, and Staff Athletic Trainer of a student-athlete's positive test result. The student-athlete will be required to notify their parent(s), guardian(s) or spouse of their positive test result. The student-athlete will be given an opportunity to rebut or explain the results prior to imposition of any sanction or required treatment or counseling program (Appeals subsection F).
   4. All individuals with prior positive drug test results will be subject to unannounced drug testing throughout their athletic eligibility as a part of their treatment program. In addition, all with prior positive or negative test results will have the same chance as any other student-athlete to be randomly selected for testing at the next and subsequent random drug tests.
   5. Regardless of test results, random drug testing will be conducted on an unannounced basis throughout the calendar year.
   6. Subsequent positive tests will result in sanctions as set forth in subsection
   7. Mandatory team testing will occur for any team qualifying for a NAIA tournament.
3. Drug Testing Based on Reasonable Suspicion
   1. "Reasonable suspicion" is defined as one founded on specific, objective facts, which if taken with rational inferences drawn from those facts, and taken as a whole strongly suggest that drug testing may produce evidence of improper use. The evidence supporting the suspicion must be reasonably reliable, documented and clearly outlined.
   2. Based upon a "reasonable suspicion" that a student-athlete is using drugs improperly, the student-athlete will be referred to the Director of Intercollegiate Athletics for testing. Following guidelines established in this Program a specimen will be taken. It will be frozen and stored untested. The documentation for the cause of a "reasonable suspicion" testing and the student-athlete's statement for why it should not be tested will be presented to the Appeals Committee. Once the Appeals Committee has rendered a decision on the prerequisite of reasonable suspicion, the specimen will either be tested or destroyed.
   3. The Director of Intercollegiate Athletics will notify the team physician or designee, that a reasonable suspicion testing is being conducted, and an appeals committee will be named as defined in Section F, 3.
   4. The student-athlete may use the self-identifying "one time exemption" at this time, if not previously used.
   5. Specimen collection and responsive actions to a positive test result shall be handled the same as those found through random testing.
   6. Mandatory team testing (under reasonable suspicion) shall occur if reliable and reasonable evidence is presented to the Director of Intercollegiate Athletics and the team physician to warrant such testing. This evidence will then be presented to an appeals committee to determine the validity of the reasonable suspicion and whether testing should be conducted.
4. Specimen Collection and Chain of Custody
   1. Upon notification, the student-athlete must present himself/herself at the specified collection site at the designated time for testing. Urine collection will be carried out under the direction of the Director of the Professional Athletic Training Program.
   2. In a private area, the student-athlete will disrobe to their underwear and be inspected by the Urine Validator. After inspection, the student-athlete will proceed into the toilet stall and void, observed, into the urine container.
   3. The student-athlete will then, following the directions of the Urine Validator, divide the sample collection of urine into two containers and seal both containers. The student-athlete will then sign the appropriate documentation stating that they were the one to seal both containers. (One container will be used for testing purposes and the other container will be frozen and stored by the testing laboratory in case there is an appeal to the test results.)
   4. Upon completion of the sample collection, the Director of the Professional Athletic Training Program, Urine Validator or designee will arrange for the sealed containers of specimen to be sent or taken to the appropriate laboratory with appropriate documentation of the chain of custody.
5. Responses to Test Results
   1. The testing laboratory will notify the Director of the Professional Athletic Training Program who will in turn notify the Team Physician of any positive results. If the "one time exemption"/self-identifying procedure (allowed only once during the student-athlete's eligibility) had been implemented, the team physician will initiate treatment and/or counseling with the intervention counselor and no further notifications or sanctions will be imposed. If the self-identifying procedure was not used, then the team physician will also notify the head coach and the Director of Athletics of the positive test results. The team physician will inform the parent(s), guardian(s) or spouse of any student-athlete who is under eighteen (18) years of age of positive test results. The student-athlete who is 18 or older will be required to notify their parent(s), guardian(s) or spouse of the positive result.  In addition to the Director of Intercollegiate Athletics, team physician, intervention counselor, head coach and the Dean of Students, a student-athlete's parent(s), guardian(s) or spouse will be notified of second and subsequent positive results by the team physician or the Director of Intercollegiate Athletics.
   2. Additional responses to positive test results, whether achieved under random, mandatory or reasonable suspicion testing will be as follows for both "performance enhancing" and "street" drugs:

• First positive test:  The student-athlete will be suspended from the intercollegiate athletics program for a minimum of 20% (rounded to the next whole number) of their next regular scheduled contest(s). Provided the Team Physician determines that the student- athlete's condition presents no health danger to himself/herself or his/her teammates, the student-athlete will be allowed to continue conditioning and practice activities. They will not participate in, travel to, or sit on the bench of the/those contest(s) they are suspended from. Non-renewal of an athletic or other grant-in-aid may also occur. To be eligible for reinstatement as a student-athlete, the individual must undergo mandatory counseling and/or a treatment program including unannounced re-testing as directed by the Team Physician.

• Second positive test:  The student-athlete will be banned from the intercollegiate athletics program for one calendar year. To be eligible for reinstatement as a student-athlete, the individual must undergo mandatory counseling and/or treatment including unannounced re-testing as directed by the Team Physician. Non-renewal of any athletic or other grant-in-aid may also result.

• Third positive test:  The student-athlete will be permanently banned from the intercollegiate athletic program and will not be eligible for reinstatement. Non-renewal of any athletic or other grant-in-aid may also result.

6. Positive testing results from NAIA, NCAA, Track Athletic Congress (TAC) and other outside sports testing agencies will also be treated as positive tests obtained under this policy, and may result in sanctions under this policy in addition to possible sanction from NAIA, NCAA, TAC and other outside agencies.
7. Any attempt to circumvent the urine collection and testing process will result in the test being considered a positive test. The student-athlete will be provided an opportunity for appeal under procedures in Section F.
8. Reinstatement: The student-athlete may petition for reinstatement from the one calendar year suspension following the second positive result under the following conditions:

1. The student-athlete must complete the mandatory counseling and/or treatment program.
2. The student athlete must consent to a comprehensive medical examination, including drug testing, and a review of all counseling or other treatment records by the team physician.
3. The student-athlete must agree to undergo unannounced, periodic drug testing with the understanding that he/she can not gain eligibility until he/she has had three consecutive negative drug test results.
4. Upon completion of all of the above (a, b and c) the team physician will forward the petition including documentation of the comprehensive medical examination, drug tests, counseling and treatment records to the Appeals Committee to render a decision.
5. Should a student-athlete test positive at any time subsequent to being reinstated, he or she will immediately and permanently be barred from the intercollegiate athletics program. Non-renewal of athletic or other grant-in-aid may follow.

V.  APPEALS

1. A student-athlete may appeal any sanction as the result of a positive drug test result. A student-athlete desiring to appeal must file a written notice of appeal with the Director of Intercollegiate Athletics within two days of notification of a positive test result.
2. A student-athlete who has been selected for testing for improper drug use based upon "reasonable suspicion" will automatically have their case presented before an Appeals committee. A specimen will be taken following guidelines established in this Program for the collection of samples. It will be frozen and stored untested until the Appeals Committee has rendered a decision as to whether there was sufficient evidence to warrant a "reasonable suspicion" testing.
3. An appeals hearing will be conducted by a three-person committee (Appeals Committee) chosen from the Drug and Alcohol Education and Testing Committee by the Chair of this committee. The student-athlete making the appeal and any committee member whom previously participated in the decision to recommend testing, will be excluded from the Appeals Committee. Evidence of the student-athlete's drug use, and all positive test results or documented reasonable suspicions will be presented to the Appeals Committee. Reasons why sanctions or testing should be imposed may be presented. The student-athlete will be given an opportunity to refute the proposed sanctions or reasonable suspicions, present evidence to support his/her contentions, call witnesses or cross-examine other witnesses.
4. The Appeals Committee will reach a decision within five working days of each hearing and will notify, in writing, the Director of Intercollegiate Athletics, the student-athlete, the Team Physician, the Head Coach and the Director of Athletics of its decision. The Director of the Professional Athletic Training Program will maintain a written record of the Appeals Committee's decision, including all evidence considered by the committee.

1. A student-athlete, who self-identifies an alcohol-related problem to any athletics department staff person, will be referred to the Director of Intercollegiate Athletics. The team physician and the intervention counselor, or other designee as deemed necessary, will then assess the student-athlete. (The student-athlete may use the "one time exemption" one time in their athletic career.)
2. Should a student-athlete have an alcohol-induced incident that causes undesirable behavior, he/she will be referred to the Director of the Professional Athletic Training Program. The team physician and intervention counselor, as deemed necessary will then assess the student-athlete.
3. Should a student-athlete be suspected of consuming alcohol prior to a practice or competition, the student-athlete will be referred to the Director of the Professional Athletic Training Program or a staff athletic trainer. A Breathalyzer test or a litmus test will be performed. If the test is positive, .02 or greater by the Breathalyzer or color change by the litmus paper, the student-athlete will be immediately withheld from practice or competition and referred to the Team Physician for assessment.
4. When the team physician determines that a student-athlete has an alcohol problem, the intervention counselor and team physician will establish a treatment plan.
5. If a student-athlete does not participate in the prescribed treatment plan, he/she will be immediately suspended from athletic participation until the student-athlete has complied with the plan.
6. Additional responses to positive alcohol test results, whether achieved under random, mandatory or reasonable suspicion testing will follow those identified in Section IV, subsection E.2. for "performance enhancing" and "street" drugs. The response for a second positive alcohol test result will have the same response imposed upon the student-athlete as that of a first positive test result for "performance enhancing" or "street" drug. Additional responses will follow sequentially (i.e.: 3rd alcohol positive = 2nd "performance enhancing"/"street" drug positive and 4th alcohol positive = 3rd "performance enhancing"/"street" drug positive).

1. The Drug and Alcohol Education and Testing Committee shall be composed of the following individuals:
   1. The Director of Intercollegiate Athletics, who shall chair the committee.
   2. One administrative staff member from the Athletics Department appointed by the Director of Intercollegiate Athletics.
   3. One Athletics Advisory Committee representative appointed by the chair of the Athletics Advisory Committee.
   4. Two head coaches appointed by the Director of Intercollegiate Athletics.
   5. A team physician and/or other staff members of the Athletics Training Staff or University staff as appointed by the Director of Intercollegiate Athletics in consultation with the Athletic Training Program.
   6. Two student-athletes appointed by the Director of Athletics.
   7. Other members maybe appointed by the Director of Athletics upon recommendation of the Drug and Alcohol Education and Testing Committee.
2. The duties of the Drug and Alcohol Education and Testing Committee shall include the following:
   1. Oversee the Drug and Alcohol Education and Testing Program for student-athletes and others at MCU
   2. Perform annual reviews of the Drug and Alcohol Education and Testing Program.
   3. Assess the drug testing protocols, procedures and correct identified irregularities.
   4. Hear student-athlete appeals as set forth in this policy.
   5. Submit an annual report of the Committee's activities to the Director of Athletics, Athletics Advisory Committee and the Chancellor of the University.  
   6. Provide advice to the Director of Athletics, Athletics Advisory Committee, Director of the Professional Athletic Training Program, Head Coaches, and student-athletes.
   7. Carry out other duties related to Drug and Alcohol Education and Testing as assigned by the Director of Athletics.

APPENDIX A

PERFORMANCE ENHANCING DRUGS

Synthetic Androgenic Anabolic Steroids (including but not limited to the following)

For the detection of anabolic steroids and their metabolites

• Bolasterone
• Bodenone
• Chlorotestosterone
• Drostanolone
• Fluoxymesterone (Halotestin)
• Furazabol
• Mesterolone
• Methandienone (Dianabol)
• Methenolone (Priimonabol)
• Methyltestosterone
• Norethandrolone
• 19-Nortestosterone (Nandrolone)
• Oxandrolone (Anavar)
• Oxymesterone (Theranabol)
• Oxymetholone (Anadrol)
• Stanozolol

Endogenous Androgenic Steroids (including but not limited to the following)

Utilized in Evaluating Endocrine Status of the Athlete

• Androstenedione
• Cis-Androsterone
• Dehydroepiandrosterone
• Etiocholanolone
• Epitestosterone
• 11B-Hydroxyandrosterone
• 11B-Hydroxyetiocholanolone
• Testosterone
• Testosterone/Epitestosterone Ratio

Blocking/Masking Agents (including but not limited to the following)

• Probenecid
• Hydrochlorthiazide
• Chlorthiazide
• Furosemide
• Triamterene
• Aprozide

APPENDIX B
STREET DRUGS

• amphetamine
• methamphetamine

• allylbarbital
• amobarbital
• butabarbital
• phenobarbital
• Phenobarbital
• secobarbital
• talbutal

• clonazepam
• chlordiazeppoxide
• demoxepam
• desalkylfurazepam
• N-desmethyldiazepam
• diazepam
• flunitrazepan
• flurazepam
• lorazepam
• nitrazepam
• oxazepam

• cocaine
• benzoylecgonine
• ecgonine

• codeine
• heroin
• hydromorphone
• hydromorphine
• levorphanol
• morphine
• morphine-3
• glucuronide
• oxycodone

• phencyclidine (PCP) and TCP

• propoxyphene
• propoxyphene major metabolites

• major metabolites in urine of marijuana